SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (868)11/14/1996 7:16:00 PM
From: John H. Farro   of 4342
 
Richard, I can't say I blame you for being a bit squeemish about buying more PRLN. It seems more speculative now than two months ago. I've speculated that they've had good results with AndroVir before, but I'd feel more secure buying this stock if I knew it for a fact. I probably have way too much invested in this stock already, so I'm in no position to buy more right now. We are getting close to the point of do-or-die. I think Paracelsian will either be over $20 by August or it will be under 50 cents. It all depends on how successful the AndroVir test went and on whether they can get the two products marketed successfully by July.

I think a celebratory bash in Ithaca would be great if the stock goes to $40, but I won't hold my breath. I doubt it will get that high by summer, but if things go successfully I wouldn't be surprised to see $20. But who knows? Predicting stock prices has never been my strong suit.

Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News